Andrew Hayes MA, MBBS, FRCS, PhD

Mr. Hayes has both a private and an NHS practice at The Royal Marsden. He is a Consultant General Surgeon and Surgical Oncologist on the Sarcoma Unit and the Skin Unit. He qualified at Oxford University and St Bartholomew's Hospital, London, and undertook his surgical training in London and a PhD in Washington DC. Mr. Hayes has a specialist practice in soft-tissue sarcoma and advanced melanoma, and operates on over 200 cases of sarcoma and another 100 cases of advanced malignant melanoma and other rare cutaneous malignancies a year. Mr. Hayes leads the isolated limb perfusion programme which provides a national service for regional chemotherapy for patients with advanced limb malignancy.

Mr. Hayes is the president of the British Sarcoma Group, the professional organization that oversees the treatment of soft tissue sarcoma in the United Kingdom, and is co-chair of the London and South East England Sarcoma Advisory Group. Within the Royal Marsden, Mr. Hayes is Clinical Director of the Rare Cancers Clinical Business Unit and Head of The Royal Marsden's Skin Unit. Mr. Hayes was awarded a Hunterian Professorship in 2002 for his research into angiogenesis as a therapeutic approach for cancer.

Hayes is a Reader in Sarcoma and Melanoma Surgery at the Institute of Cancer Research and is the Team Leader of the Sarcoma and Melanoma Surgery Research Group at the ICR. He has a laboratory research program in the ICR investigating new therapies for extremity malignancies using isolated limb perfusion and is a chief investigator in clinical trials of new therapeutic agents for the treatment of advanced limb malignancies. He has published widely in all aspects of the treatment of sarcoma and melanoma and lectures nationally and internationally on all aspects of these diseases.